Results 91 to 100 of about 73,504 (266)

Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study

open access: yesThe Lancet Public Health
Summary: Background: Paediatric pneumococcal conjugate vaccine (PCV) programmes in England using seven-valent PCV (PCV7) in 2006 and 13-valent PCV (PCV13) in 2010 have reduced vaccine-type invasive pneumococcal disease, but the overall effect has been ...
Yoon Hong Choi, PhD   +4 more
doaj   +1 more source

Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study

open access: yesBMC Infectious Diseases, 2007
Background Polysaccharide pneumococcal vaccine is recommended for use in HIV-infected adults in Brazil but there is uncertainty about its effectiveness in this patient population. The main objective of this study was to assess the effectiveness of the 23-
Veras Maria   +3 more
doaj   +1 more source

Pneumococcal vaccine development

open access: yesExpert Review of Vaccines, 2004
A 7-valent pneumococcal conjugate vaccine has demonstrated an impact on pneumococcal bacteremia in the immunized pediatric population, extending to nonimmunized adults via herd immunity. A considerable reduction of all-cause pediatric pneumonia has also been found.
openaire   +2 more sources

The rise of companies from emerging markets in global health governance: opportunities and challenges [PDF]

open access: yes, 2014
The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies.
ANNE ROEMER-MAHLER   +23 more
core   +1 more source

PROGNOSTICATION OF VACCINATION EFFICACY

open access: yesПедиатрическая фармакология, 2010
The article focuses on the study of protective immunity in vaccination with pneumococcal conjugated 7-valent vaccine (PCV7) against related vaccine serotypes.
N.F. Snegova   +3 more
doaj   +2 more sources

Expert panel opinion on adult pneumococcal vaccination in the post-COVID era (NAP- EXPO Recommendations-2024)

open access: yesLung India
Introduction Pneumococcal diseases pose a significant public health concern in India, with substantial morbidity and mortality, with the elderly and those with coexisting medical conditions being most at risk.
Parvaiz A. Koul   +22 more
doaj   +1 more source

The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities [PDF]

open access: gold, 2021
Yan Li   +5 more
openalex   +1 more source

Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID [PDF]

open access: yes, 2018
To the Editor: Disease-specific studies focused on infection risk in common variable immune deficiencies (CVIDs) are needed to define strategies for controlling respiratory infections predominantly due to bacteria such as Streptococcus pneumoniae and ...
Camilli, Romina   +10 more
core   +1 more source

Global Coverage of Pneumococcal Conjugate Vaccine (PCV) and Serotype Distribution after Receiving Vaccine among Targeted PCV Vaccine Countries: A Systematic Review

open access: yesمجله اپیدمیولوژی ایران, 2020
Background and Objectives: After the introduction of the pneumococcal vaccine, an increase has been observed in the disease due to nonspecific stereotypes of the vaccine.
S Rahmani   +4 more
doaj  

The Update, February 13, 2012 [PDF]

open access: yes, 2012
The Update is a bi-weekly web newsletter published by the Iowa Department of Public Health's Bureau of Family Health. It is posted the second and fourth week of every month, and provides useful job resource information for departmental health care ...

core  

Home - About - Disclaimer - Privacy